Concepts (68)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Skilled Nursing Facilities | 3 | 2020 | 31 | 1.400 |
Why?
|
| Candida | 3 | 2021 | 19 | 1.050 |
Why?
|
| beta-Lactamases | 2 | 2020 | 101 | 0.720 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2018 | 41 | 0.590 |
Why?
|
| Carbapenems | 1 | 2018 | 46 | 0.590 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2018 | 55 | 0.590 |
Why?
|
| Candidiasis | 3 | 2025 | 28 | 0.580 |
Why?
|
| Cross Infection | 2 | 2025 | 309 | 0.570 |
Why?
|
| Chicago | 7 | 2025 | 953 | 0.510 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2015 | 73 | 0.450 |
Why?
|
| Infection Control | 1 | 2015 | 173 | 0.420 |
Why?
|
| Disease Outbreaks | 2 | 2024 | 81 | 0.260 |
Why?
|
| Illinois | 3 | 2022 | 250 | 0.230 |
Why?
|
| Vaccination | 1 | 2024 | 35 | 0.220 |
Why?
|
| Sexual and Gender Minorities | 1 | 2022 | 28 | 0.190 |
Why?
|
| Humans | 11 | 2025 | 27309 | 0.190 |
Why?
|
| Dermatomycoses | 1 | 2021 | 5 | 0.180 |
Why?
|
| Ventilators, Mechanical | 1 | 2020 | 27 | 0.170 |
Why?
|
| Hospitals, Pediatric | 1 | 2020 | 3 | 0.170 |
Why?
|
| Skin | 1 | 2021 | 130 | 0.170 |
Why?
|
| Bacterial Proteins | 1 | 2020 | 91 | 0.160 |
Why?
|
| Integrons | 1 | 2018 | 4 | 0.150 |
Why?
|
| Cluster Analysis | 1 | 2018 | 47 | 0.150 |
Why?
|
| HIV Infections | 1 | 2022 | 477 | 0.140 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 1807 | 0.120 |
Why?
|
| Adolescent | 4 | 2024 | 2185 | 0.110 |
Why?
|
| Hospitals | 1 | 2015 | 170 | 0.110 |
Why?
|
| Genomics | 2 | 2025 | 68 | 0.100 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2011 | 19 | 0.090 |
Why?
|
| Aged | 3 | 2024 | 9119 | 0.090 |
Why?
|
| Influenza, Human | 1 | 2011 | 47 | 0.090 |
Why?
|
| Surveys and Questionnaires | 1 | 2015 | 1156 | 0.080 |
Why?
|
| Genome, Fungal | 1 | 2025 | 4 | 0.060 |
Why?
|
| Whole Genome Sequencing | 1 | 2025 | 9 | 0.060 |
Why?
|
| Phylogeny | 1 | 2025 | 54 | 0.060 |
Why?
|
| Male | 4 | 2025 | 14887 | 0.060 |
Why?
|
| Female | 4 | 2025 | 15334 | 0.060 |
Why?
|
| Infant | 2 | 2020 | 517 | 0.060 |
Why?
|
| Infant, Newborn | 2 | 2020 | 562 | 0.060 |
Why?
|
| Child, Preschool | 2 | 2020 | 624 | 0.060 |
Why?
|
| Viral Vaccines | 1 | 2024 | 3 | 0.060 |
Why?
|
| Genome, Viral | 1 | 2024 | 14 | 0.060 |
Why?
|
| Middle Aged | 3 | 2025 | 9068 | 0.060 |
Why?
|
| Antibodies, Viral | 1 | 2024 | 58 | 0.060 |
Why?
|
| Adult | 3 | 2024 | 7946 | 0.050 |
Why?
|
| Virus Shedding | 1 | 2023 | 7 | 0.050 |
Why?
|
| Respiratory System | 1 | 2023 | 9 | 0.050 |
Why?
|
| Young Adult | 2 | 2024 | 2032 | 0.050 |
Why?
|
| RNA, Viral | 1 | 2023 | 48 | 0.050 |
Why?
|
| Specimen Handling | 1 | 2023 | 44 | 0.050 |
Why?
|
| Homosexuality, Male | 1 | 2022 | 28 | 0.050 |
Why?
|
| Child | 2 | 2020 | 1269 | 0.050 |
Why?
|
| Minority Groups | 1 | 2022 | 80 | 0.050 |
Why?
|
| Population Surveillance | 1 | 2022 | 115 | 0.050 |
Why?
|
| Nursing Homes | 1 | 2021 | 42 | 0.040 |
Why?
|
| Transitional Care | 1 | 2020 | 4 | 0.040 |
Why?
|
| Long-Term Care | 1 | 2020 | 61 | 0.040 |
Why?
|
| Prevalence | 1 | 2020 | 458 | 0.040 |
Why?
|
| United States | 1 | 2022 | 2078 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2011 | 44 | 0.020 |
Why?
|
| Age Distribution | 1 | 2011 | 87 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2011 | 71 | 0.020 |
Why?
|
| Electronic Health Records | 1 | 2011 | 74 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2011 | 133 | 0.020 |
Why?
|
| Logistic Models | 1 | 2011 | 398 | 0.020 |
Why?
|
| Pandemics | 1 | 2011 | 243 | 0.020 |
Why?
|
| Emergency Service, Hospital | 1 | 2011 | 270 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2011 | 3551 | 0.010 |
Why?
|